AKT1 and cancer: The Rac and Cdc42 inhibitors, EHop-016 and MBQ-167, are potent inhibitors of cancer cell migration and metastasis, as our group has demonstrated in different cancer cell types (25– 27, 29, 30, 32, 46–48).